Search Results - Willy Hugo

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments by Xueyan Wang, Xiaowei Liu, Willy Hugo, Lu Si, Hubing Shi

    Published in Frontiers in Immunology (2022-10-01)
    Get full text
    Article


  2. 2

    Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors by Lizhong Ding, Lizhong Ding, Lu Sun, Lu Sun, Melissa T. Bu, Yanjun Zhang, Yanjun Zhang, Lauren N. Scott, Robert M. Prins, Robert M. Prins, Robert M. Prins, Robert M. Prins, Maureen A. Su, Maureen A. Su, Maureen A. Su, Maureen A. Su, Melissa G. Lechner, Melissa G. Lechner, Willy Hugo, Willy Hugo, Willy Hugo

    Published in Frontiers in Immunology (2023-06-01)
    Get full text
    Article


  3. 3

    A pathologically expanded, clonal lineage of IL-21–producing CD4+ T cells drives inflammatory neuropathy by Maryamsadat Seyedsadr, Madison F. Bang, Ethan C. McCarthy, Shirley Zhang, Ho-Chung Chen, Mahnia Mohebbi, Willy Hugo, Jason K. Whitmire, Melissa G. Lechner, Maureen A. Su

    Published in The Journal of Clinical Investigation (2024-08-01)
    Get full text
    Article


  4. 4

    TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial by Richard G. Everson, Willy Hugo, Lu Sun, Joseph Antonios, Alexander Lee, Lizhong Ding, Melissa Bu, Sara Khattab, Carolina Chavez, Emma Billingslea-Yoon, Andres Salazar, Benjamin M. Ellingson, Timothy F. Cloughesy, Linda M. Liau, Robert M. Prins

    Published in Nature Communications (2024-05-01)
    Get full text
    Article


  5. 5

    Author Correction: TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial by Richard G. Everson, Willy Hugo, Lu Sun, Joseph Antonios, Alexander Lee, Lizhong Ding, Melissa Bu, Sara Khattab, Carolina Chavez, Emma Billingslea-Yoon, Andres Salazar, Benjamin M. Ellingson, Timothy F. Cloughesy, Linda M. Liau, Robert M. Prins

    Published in Nature Communications (2024-06-01)
    Get full text
    Article


  6. 6

    Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors by Lu Sun, Jenny C. Kienzler, Jeremy G. Reynoso, Alexander Lee, Eileen Shiuan, Shanpeng Li, Jiyoon Kim, Lizhong Ding, Amber J. Monteleone, Geoffrey C. Owens, Joanna J. Phillips, Richard G. Everson, David Nathanson, Timothy F. Cloughesy, Gang Li, Linda M. Liau, Willy Hugo, Won Kim, Robert M. Prins

    Published in The Journal of Clinical Investigation (2023-09-01)
    Get full text
    Article


  7. 7

    Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression by Angel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, Justin Saco, Helena Escuin-Ordinas, Gabriel Abril Rodriguez, Jesse M. Zaretsky, Lu Sun, Willy Hugo, Xiaoyan Wang, Giulia Parisi, Cristina Puig Saus, Davis Y. Torrejon, Thomas G. Graeber, Begonya Comin-Anduix, Siwen Hu-Lieskovan, Robert Damoiseaux, Roger S. Lo, Antoni Ribas

    Published in Cell Reports (2017-05-01)
    Get full text
    Article


  8. 8

    Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity by Evan R. Abt, Khalid Rashid, Thuc M. Le, Suwen Li, Hailey R. Lee, Vincent Lok, Luyi Li, Amanda L. Creech, Amanda N. Labora, Hanna K. Mandl, Alex K. Lam, Arthur Cho, Valerie Rezek, Nanping Wu, Gabriel Abril-Rodriguez, Ethan W. Rosser, Steven D. Mittelman, Willy Hugo, Thomas Mehrling, Shanta Bantia, Antoni Ribas, Timothy R. Donahue, Gay M. Crooks, Ting-Ting Wu, Caius G. Radu

    Published in The Journal of Clinical Investigation (2022-08-01)
    Get full text
    Article


Search Tools: